Health
Australian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients – Monash University
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support…
05 August 2021
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill COVID-19 patients, but does not yield the same positive outcomes…
Continue Reading
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News20 hours agoWest End icon closes doors
-
General22 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News24 hours agoBetty’s Burgers National Burger Day